Abstract | Background: Methods: The clinical endpoint was a major adverse cardiovascular and cerebrovascular event (MACCEs), including cardiac-related death, non-fatal myocardial infarction, ischemia-driven revascularization, and stroke. The TyG index was calculated as = ln [( triglyceride level, mg/dL) × ( glucose level, mg/dL)÷2] under fasting conditions. Results: The study included 2,030 prediabetic patients with ACS. Patients were followed up for 2.5 years, during which the total incidence of MACCEs was 12%. After adjustment for covariates, the TyG index was found to be predictive of prediabetes with ACS (HR 4.942, 95%CI: 3.432-6.115, P<0.001). Using propensity score matching, 574 pairs were successfully matched, and the two groups were analyzed in terms of survival. This showed that there was a significantly greater incidence of MACCEs in patients with high TyG indices (HR 3.526, 95%CI: 2.618-4.749, P<0.001), mainly due to ischemia-driven revascularization and stroke. Conclusions: The TyG index independently predicts future MACCEs and may be an important prognostic indicator for patients with prediabetes and ACS.
|
Authors | Qianyun Guo, Xunxun Feng, Bin Zhang, Guangyao Zhai, Jiaqi Yang, Yang Liu, Yuyang Liu, Dongmei Shi, Yujie Zhou |
Journal | Frontiers in endocrinology
(Front Endocrinol (Lausanne))
Vol. 13
Pg. 843072
( 2022)
ISSN: 1664-2392 [Print] Switzerland |
PMID | 35295991
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2022 Guo, Feng, Zhang, Zhai, Yang, Liu, Liu, Shi and Zhou. |
Chemical References |
- Biomarkers
- Blood Glucose
- Triglycerides
- Glucose
|
Topics |
- Acute Coronary Syndrome
(complications, diagnosis)
- Biomarkers
- Blood Glucose
- Glucose
- Humans
- Insulin Resistance
- Prediabetic State
(complications)
- Risk Assessment
- Risk Factors
- Stroke
(epidemiology, etiology)
- Time Factors
- Triglycerides
|